Latest Insider Transactions at Singular Genomics Systems, Inc. (OMIC)
This section provides a real-time view of insider transactions for Singular Genomics Systems, Inc. (OMIC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Singular Genomics Systems, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Singular Genomics Systems, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 01
2021
|
James E Flynn > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,500,000
+22.45%
|
$33,000,000
$22.0 P/Share
|
|
Jun 01
2021
|
James E Flynn > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
7,612,019
+35.86%
|
$129,404,323
$17.6 P/Share
|
|
Jun 01
2021
|
Kim P. Kamdar |
BUY
Conversion of derivative security
|
Indirect |
4,395,633
+49.44%
|
-
|
|
Jun 01
2021
|
Alexandria Venture Investments, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,645,985
+50.0%
|
-
|
|
Jun 01
2021
|
Andrew Spaventa Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
889,028
+33.15%
|
$15,113,476
$17.6 P/Share
|
|
May 20
2021
|
Michael J Pellini |
BUY
Conversion of derivative security
|
Indirect |
96,944
+50.0%
|
-
|